Stocksigma LogoStocksigma Logo

Bal Pharma Q2 Results: Consolidated Net Profit Surges 99.8% YoY

Bal Pharma reported a 21.5% YoY rise in consolidated revenue from operations to ₹8,994.69 lakhs for the quarter ended 30th Sep'26, up from ₹7,402.49 lakhs

Bal Pharma Q2 Results: Consolidated Net Profit Surges 99.8% YoY

Bal Pharma Ltd · Outcome · 11 Nov 2026, 11:46 pm

Bal Pharma Q2 Results: Consolidated Net Profit Surges 99.8% YoY Bal Pharma reported a 21.5% YoY rise in consolidated revenue from operations to ₹8,994.69 lakhs for the quarter ended 30th Sep'26, up from ₹7,402.49 lakhs in Q2 of the prior year. Consolidated net profit surged 99.8% YoY to ₹143.31 lakhs compared to ₹71.73 lakhs, with basic EPS improving to ₹0.89 from ₹0.45. Additionally, the company confirmed zero deviation in the utilization of ₹210.00 lakhs raised via preferential warrant allotments earmarked for its Greenfield API manufacturing facility in Yadgiri, Karnataka.

Original exchange filing (PDF)

More announcements from Bal Pharma Ltd

All Bal Pharma Ltd announcements